Antipodes Partners’s Elanco Animal Health ELAN Stock Holding History

Antipodes Partners’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42.3K	Buy	+1,720	New	+$39.8K	﹤0.01%	116

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Antipodes Partners's ELAN Position: Q2 2026 in Review

Antipodes Partners opened a new position in Elanco Animal Health (ELAN) in Q2 2026: 1,720 shares worth $42.3K. The stake represents ﹤0.01% of the portfolio and ranks #116 among its holdings.

520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

Antipodes Partners held 1,720 shares of Elanco Animal Health worth $42.3K as of Q2 2026.
Elanco Animal Health was a new Antipodes Partners position in Q2 2026.
Elanco Animal Health made up ﹤0.01% of Antipodes Partners's portfolio in Q2 2026, its #116 holding.
520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.